Sunday, August 02, 2015 11:57:15 PM
Jul 23 2015, 08:04 ET | About: Dr Pepper Snapple Group... (DPS) | By: Niloofer Shaikh, SA News Editor
Dr Pepper Snapple (NYSE:DPS): Q2 EPS of $1.14 beats by $0.04.
Revenue of $1.66B (+1.8% Y/Y) beats by $10M.
Press Release
http://seekingalpha.com/news/2650095-dr-pepper-snapple-beats-by-0_04-beats-on-revenue?uprof=45#email_link
Dr Pepper Snapple Group Reports Second Quarter 2015 Results
Thu July 23, 2015 8:00 AM|PR Newswire | About: DPS
PLANO, Texas, July 23, 2015 /PRNewswire/ -- Dr Pepper Snapple Group, Inc. (DPS) reported second quarter 2015 EPS of $1.14 compared to $1.06 in the prior year period. Core EPS were $1.13, up 7%, compared to $1.06 in the prior year period. Year-to-date, the company reported earnings of $1.95 per diluted share compared to $1.84 per share in the prior year period. Core EPS were $1.94, up 8%, compared to $1.80 in the prior year period.
For the quarter, reported net sales increased 1%, which included favorable product, package and segment mix and a 1% increase in sales volumes, partially offset by 2 percentage points of unfavorable foreign currency translation. Reported segment operating profit (SOP) increased 6%, or $24 million, on net sales growth, ongoing productivity improvements and favorable commodity costs, partially offset by 1 percentage point of unfavorable foreign currency translation.
Reported income from operations for the quarter was $369 million, including $5 million in unrealized commodity mark-to-market gains. Reported income from operations was $348 million in the prior year period. Core income from operations was $365 million, up 5% compared to the prior year period.
Year-to-date, reported net sales increased 3%, and reported income from operations was $639 million, including $4 million of unrealized commodity mark-to-market gains. Foreign currency translation negatively impacted reported net sales by 1% and reported income from operations by 2%. Reported income from operations was $608 million in the prior year period, including $12 million of unrealized commodity mark-to-market gains. Core income from operations was $636 million, up 7% compared to the prior year period.
DPS President and CEO Larry Young said, "We've had a good start to the year, and I'm proud of what our teams have been able to accomplish in this competitive environment. They remained focused on our strategy and continued to deliver against our key priorities. Year-to-date, we grew volume and dollar share in both the CSD and shelf-stable juice categories in Nielsen measured markets and gained or held distribution and availability across our portfolio."
Young continued, "We've brought innovation to the market that addresses consumers' evolving needs, and Rapid Continuous Improvement (RCI) continues to drive growth and productivity across the business. I'm confident that our teams will continue to execute against our plans for the balance of the year."
More...
http://seekingalpha.com/pr/14176295-dr-pepper-snapple-group-reports-second-quarter-2015-results
Recent KDP News
- Keurig Dr Pepper Reports Q1 2024 Results and Reaffirms Fiscal 2024 Guidance • PR Newswire (US) • 04/25/2024 11:00:00 AM
- Keurig Dr Pepper to Report First Quarter 2024 Results and Host Conference Call • PR Newswire (US) • 03/28/2024 08:15:00 PM
- Keurig Dr Pepper to Outline Strategy and Value-creation Opportunities at Investor Event • PR Newswire (US) • 03/19/2024 12:00:00 PM
- Introducing the Next Chapter of the Keurig® K-Cup® Pod System Product Portfolio • PR Newswire (US) • 03/13/2024 05:00:00 PM
- Keurig® Reimagines Single Serve Coffee with the Unveil of its Next-Generation Coffee and Brewer Innovation • PR Newswire (Canada) • 03/13/2024 05:00:00 PM
- Keurig® Reimagines Single Serve Coffee with the Unveil of its Next-Generation Coffee and Brewer Innovation • PR Newswire (Canada) • 03/13/2024 05:00:00 PM
- Keurig® Reimagines Single Serve Coffee with the Unveil of its Next-Generation Coffee and Brewer Innovation • PR Newswire (US) • 03/13/2024 05:00:00 PM
- Introducing the Next Chapter of the Keurig® K-Cup® Pod System Product Portfolio • PR Newswire (Canada) • 03/13/2024 05:00:00 PM
- Keurig Dr Pepper to Webcast 2024 Strategy Review and Investor Update on March 19 • PR Newswire (US) • 03/12/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:57:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:48:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:45:33 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 10:18:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:38:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:29:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:28:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:27:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:26:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:24:36 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/06/2024 10:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:13:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:12:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:11:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:10:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:08:41 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM